Advocacy intelligence hub — real-time data for patient organizations
Orphalan — PHASE3
Fondation Ophtalmologique Adolphe de Rothschild
Yale University — NA
DSciLab Co., Ltd. — EARLY_PHASE1
Prime Medicine, Inc.
Assiut University
Centre Hospitalier Universitaire de Saint Etienne — NA
GeneCradle Inc — PHASE1, PHASE2
Thomas Damgaard Sandahl
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Foundation grants
Copay cards
Travel grants
Foundation Grants3
Copay Assistance1
Penicillamine
Bausch Health
Patient Assistance Programs1
Galzin
Eton Pharmaceuticals
Travel Grants2
Galzin
(Zinc acetate)Orphan drugEton Pharmaceuticals, Inc
Penicillamine
(PENICILLAMINE)Orphan drugstandardEndo USA, Inc.
Ultragenyx Medical Director
Ultragenyx Pharmaceuticals Inc.
📍 Little Rock, Arkansas
Michael L Schilsky, MD FAASLD
Yale University
📍 New Haven, Connecticut
Marcelo Serra, PhD
HIBA
📍 Buenos Aires, Buenos Aires
Liang Peng, Doctor, O.M.D, L. Ac
Third Affiliated Hospital, Sun Yat-Sen University
📍 HOUSTON, TX
Arndt Rolfs, Prof. Dr.
CENTOGENE GmbH Rostock
Aurélia POUJOIS, MD
Fondation A. de Rothschild